Capital Analysts LLC’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.8M Buy
205,091
+15,821
+8% +$1.46M 0.46% 50
2026
Q1
$15.3M Buy
189,270
+151,235
+398% +$12.6M 0.4% 56
2025
Q4
$2.93M Buy
38,035
+9,146
+32% +$700K 0.08% 199
2025
Q3
$2.17M Buy
28,889
+4,344
+18% +$310K 0.06% 226
2025
Q2
$1.68M Buy
24,545
+8,004
+48% +$504K 0.06% 227
2025
Q1
$995K Buy
16,541
+8,823
+114% +$531K 0.04% 264
2024
Q4
$454K Sell
7,718
-5,587
-42% -$348K 0.02% 344
2024
Q3
$860K Buy
13,305
+789
+6% +$48.3K 0.04% 258
2024
Q2
$765K Buy
+12,516
New +$750K 0.03% 281

Other funds holding AVEM

Capital Analysts LLC's AVEM Position: Q2 2026 in Review

Capital Analysts LLC increased its Avantis Emerging Markets Equity ETF (AVEM) stake by 8.4% in Q2 2026, buying an estimated $1.46M and bringing the position to 205,091 shares worth $19.8M. The position accounts for 0.46% of the portfolio, ranked #50.

Capital Analysts LLC first reported a position in AVEM in Q2 2024 and has held it in 9 quarters since. 1,006 funds tracked by Wall St. Rank hold AVEM as of Q2 2026.

  • Capital Analysts LLC held 205,091 shares of Avantis Emerging Markets Equity ETF worth $19.8M as of Q2 2026.
  • Capital Analysts LLC bought 15,821 Avantis Emerging Markets Equity ETF shares in Q2 2026, an estimated $1.46M.
  • Avantis Emerging Markets Equity ETF made up 0.46% of Capital Analysts LLC's portfolio in Q2 2026, its #50 holding.
  • Capital Analysts LLC first reported a position in Avantis Emerging Markets Equity ETF in Q2 2024 and has held it in 9 quarters since.
  • 1,006 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.